Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission
- 1 January 1995
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 242 (2), 53-58
- https://doi.org/10.1007/bf00887815
Abstract
Magnetic resonance imaging of multiple sclerosis (MS) patients often shows active inflammatory lesions despite clinical remission. No immunological marker of disease activity has been identified in these patients. Concentrations of neopterin, interleukin-2 (IL-2), soluble interleukin-2 receptor (sIL-2R) and tumour necrosis factor-α (TNF-α) were measured in the serum and cerebrospinal fluid of 19 clinically-inactive MS patients and compared with those of 19 non-inflammatory controls. Cerebrosipnal fluid (CSF) neopterin concentrations were significantly higher in the MS group than in controls (mean 9.1 mM vs 3.4 nM,Pa concentrations revealed no significant differences between MS patients and controls. We conclude that CSF neopterin concentration may correlate with disease activity in asymptomatic patients.Keywords
This publication has 47 references indexed in Scilit:
- Elevated Interleukin 2 Levels in Serum and Cerebrospinal Fluid of Patients with Relapsing-Remitting Multiple SclerosisAnnals of the New York Academy of Sciences, 1992
- Tumor necrosis factor-α enhances interferon-γ-mediated class II antigen expression on astrocytesJournal of Neuroimmunology, 1989
- Tumor necrosis factor alpha (TNFα) and neurological diseases Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumoursJournal of Neuroimmunology, 1989
- Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patientsAnnals of Neurology, 1988
- Heparin to Prevent Pulmonary Embolism and Venous ThrombosisNew England Journal of Medicine, 1988
- Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?Acta Neurologica Scandinavica, 1988
- Elevated Serum Interleukin-2 Levels in Chronic Progressive Multiple SclerosisNew England Journal of Medicine, 1988
- CSF neopterin as marker of disease activity in multiple sclerosisActa Neurologica Scandinavica, 1987
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.The Journal of Experimental Medicine, 1984
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983